Navigation Links
Avion Pharmaceuticals, LLC., announces further expansion of their Women's Health Sales Team
Date:4/16/2013

ATLANTA, April 16, 2013 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, announces the addition of 45 sales representatives to support their Women's Health Care and Dermatology portfolio of products.  The new sales team has joined the existing 40 representatives in promoting the Prenate® prenatal vitamin family of products along with Nicomide® for inflammatory acne.  In addition, the expanded Avion sales team of 85 representatives will be focused on the launch of FeRiva™ a new prescription iron supplement.  FeRiva delivers two forms of iron utilizing a patented INNER CAP multi-compartment capsule technology.  FeRiva contains 75 mg of elemental iron that includes Ferrochel® (Ferrous Bis-glycinate Sulfate and Ferronyl® (Carbonyl Iron), two preferred forms of iron for improved tolerability and compliance.

"The expansion of our sales team provides the critical level of sales support needed to effectively promote our portfolio of products to our prescriber community.  Avion is well-positioned for continued growth by providing a suite of products that will meet patient needs and our team of sales professionals is poised for success," stated Mike Sullivan , Vice President, Sales and Marketing for Avion Pharmaceuticals. 

"Avion Pharmaceuticals is excited to continue our focused efforts on nurturing the health and nutritional needs of women.  Our sales force expansion is being executed at the optimal juncture in our corporate history to support the progress we have planned for continued growth," added Mark Pugh , CEO for Avion Pharmaceuticals.

About Avion Pharmaceuticals, LLC.
Avion Pharmaceuticals, LLC. is a Specialty Pharmaceutical company formed to develop and market a portfolio of innovative pharmaceutical products in the Women's Heath and Dermatology therapeutic areas.  Avion Pharmaceuticals focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development drugs to fulfill unmet medical needs.  For additional information about Avion Pharmaceuticals please contact the company at 678-325-5188.

Ferronyl is a registered trademark of ISP Investments, Inc. PureWay-C is a registered trademark of Innovation Laboratories, Inc. Ferrochel is a registered trademark of Albion Laboratories, Inc. covered by U.S. Patents 6,716,814 & 7,838,042.
Covered by one or more claims of U.S. Patent # 7,670,612 (INNERCAP Technologies, Inc).

FeRiva™ is a trademark of Avion Pharmaceuticals, LLC. Under license from Acella Pharmaceuticals, LLC. All rights reserved.

 


'/>"/>
SOURCE Avion Pharmaceuticals, LLC.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Avion Pharmaceuticals, LLC., Launches Prenate Mini
2. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
3. Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
4. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
5. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
6. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
7. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results
8. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Fourth Quarter and Year-End 2012 Financial Results
9. OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012
10. Pipeline Initiatives, Partnerships to Drive Growth - Research Report on Pfizer, Theravance, ISIS Pharmaceuticals, Infinity Pharmaceuticals and Ironwood
11. Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... -- Eli Lilly and Company (NYSE: LLY ) has ... pending patent litigation in the U.S. District Court for the ... Cialis ® (tadalafil) unit dose patent. This patent was ... of the agreement, Cialis exclusivity is now expected to end ... unit dose patent for Cialis is valid and infringed by ...
(Date:7/11/2017)... , July 11, 2017  Dr. Echenberg, founder of Echenberg Institute, ... program to patients who suffer from painful intercourse and other painful pelvic ... vaginal atrophy due to menopause. ... VuVatech LLC ... created by Sarasota, Florida -based start-up company, VuVatech LLC, ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston Hotel, ... unparalleled access to global decision makers and innovative biotech ... life science leaders during two impactful days. BioPharm America ... delegates with additional networking opportunities with 4,500+ life science ...
Breaking Medicine Technology:
(Date:7/26/2017)... ... July 26, 2017 , ... The ... Process Validation and Process Validation Statistics Conferences in Bethesda, Maryland, 12 – ... challenges faced by process validation professionals and statisticians today. , “These conferences ...
(Date:7/26/2017)... ... ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission of ... to announce the 106 college athletes with type 1 diabetes who will receive scholarships ... Type 1 Foundation has bestowed a total of 271 college scholarships to athletes with ...
(Date:7/26/2017)... ... July 26, 2017 , ... IDC-Eating Disorder Care ... the treatment program located in Royal Oak, Michigan. IDC, formerly known as ... focused on providing the highest standards in the field of eating disorder treatment in ...
(Date:7/26/2017)... Wheaton, IL (PRWEB) , ... July 26, 2017 , ... Wendy M. Musielak, ... Cores LLP, was elected as DuPage County Bar Association’s third Vice President earlier this year. ... succeeding to the office of the second Vice President, in accordance with the organization’s by-laws. ...
(Date:7/25/2017)... ... July 25, 2017 , ... “Now Hiring!” is a popular phrase at ... company has achieved record-breaking sales for over 30 consecutive years and now plans to ... The upcoming year offers excitement and growth at HDIS, following the company’s acquisition by ...
Breaking Medicine News(10 mins):